Pharma companies Biotehnos and Rompharm, both based in Romania, had seen significant declines in sales of their Alflutop and Rumalon brands in Russia.
On investigation, it became apparent that the success of both brands had made them a lucrative target for counterfeiters, to the extent that almost half of the branded drugs in the Russian market were showing as fake.
Not only did these counterfeits impact on sales by replacing genuine products with those of unknown quality, the high percentage of fakes meant that doctors had lost confidence in the brands and stopped prescribing them, causing patients to suffer.
Following discussions with Eltronis, holographic labels were recommended for both brands to help protect them from the counterfeiters. Importantly, the solutions also focused on re-building brand confidence among medical professionals.
Pete Smallwood, Business Development Manager for Eltronis, said: “Not only did our holographic labels counter the decreases seen in sales but, as doctors once again felt confident in prescribing these medicines, patients were able to benefit from receiving the best treatment for their illnesses.”
Eltronis designed and manufactured a security label with a hot-stamp hologram for Alflutop to use on both its ampoules and branded cartons. The sophisticated design used a combination of high quality overt and covert embossed security features. This, combined with Eltronis’ advanced adhesive technology, which allows the label to be applied to both the ampoule and its packaging, created an effective security solution that was virtually impossible to counterfeit and provided quick and easy authentication of genuine Alflutop products.
Rompharm chose a demetallised hologram label for Rumalon across both its ampoule and carton packaging. This integrated the latest holographic security techniques, including a 3D glass relief, and was rolled out across the portfolio.
The high-quality security holograms gave an immediate means of verification for both brands and campaigns were undertaken to ensure doctors were clear on what features to look for and to help identify any fakes.
Within a year, confidence increased significantly amongst medical professionals, and the latest data has shown that sales volumes have now recovered to previous levels.
![“Another key [UDI] benefit, because we're calling that product by the same name across the healthcare supply chain… rich and robust data that we can access around supply consumption and utilization rates. One of the buzz terms we've heard during the COVID-19 crisis was what's my burn rate? How fast am I going through gowns, masks, gloves?” – Mike Schiller, Senior Director at AHRMM](https://img.healthcarepackaging.com/files/base/pmmi/all/image/2020/08/UDI.5f4d326e41d53.png?auto=format&fit=crop&h=146&w=340)
